臨床試験イメージングの市場規模、シェア、動向分析レポート：モダリティ別、治療分野別、サービス別、最終用途別、地域別、セグメント別予測、2025年～2030年

臨床試験イメージング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験イメージングの市場規模は、2025年から2030年にかけてCAGR 7.8％を記録し、2030年には19億1,000万米ドルに達すると予測されています。

慢性疾患を治療するための新薬や治療法を発見するための研究開発費の増加が、業界の成長を後押ししています。体内検査から得られる画像は、薬剤活性の判定に使用されます。臨床試験用画像は、迅速で詳細かつ正確なスクリーニングを提供します。臨床試験イメージング診断のニーズは、臨床試験のあらゆるフェーズで急速に高まっています。臨床試験における医用画像は、主要、定量的、代替バイオマーカーとして使用されます。

臨床試験デザインには、患者集団の選択、バイオマーカーに基づく層別化、治療割り付けのためのさまざまな方法、効率的で信頼性の高いエンドポイントの選択と代替エンドポイントの検証、サンプルサイズの計算、試験シミュレーション、適応試験セットアップ、統計解析、中間解析、EMAやFDAなどの規制当局と試験デザインについて議論したり試験結果を弁護したりするためのクライアントの対応支援などが含まれます。

市場の企業は、臨床開発強化のための分析試験サービス、薬物動態、読影、薬力学サービスを提供しています。IXICO社は、神経科学の臨床試験を促進する先進技術を提供しています。同社によるイメージングバイオマーカーは、神経イメージングに使用される治療法の安全性と有効性の測定に役立ちます。イメージングバイオマーカーは放射線学的読影に有効です。これにより、中枢神経用のMRIスキャンの読影が可能になり、薬剤の安全性と被験者の適格性に関する継続的なモニタリングの評価が強化されます。

臨床試験イメージング市場レポートハイライト

• 読影・分析サービス部門は2024年に30.95%の最大市場シェアを占め、2025年から2030年にかけてCAGR 8.4%で成長すると予測され、臨床研究における画像データの正確性と信頼性を確保する上で重要な役割を果たすことが強調されています。
• バイオテクノロジーおよび製薬企業セグメントは、2024年に28.7％の最大シェアを占めました。このセグメントの優位性の要因は、慢性疾患を治療するための新薬や治療法の開発の必要性です。
• 腫瘍学セグメントは2024年に23.63%の最大シェアを占めました。がん患者の高い有病率と、様々なタイプのがんを治療するための新しく革新的な治療法の絶え間ないニーズが、市場の成長を促進すると予想されています。
• 開発業務受託機関（CRO）分野は、慢性疾患に対する新薬や治療法の開発に不可欠な役割を担っていることから、予測期間のCAGRは8.5%で大幅な成長が見込まれています。
• 北米は、高齢者人口の増加、慢性疾患、治療オプションへの需要の高まりにより、2024年の売上高シェア47.93%で市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験イメージング市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• 臨床試験イメージング市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 臨床試験イメージング市場：モダリティ別推定・動向分析

• セグメントダッシュボード
• 臨床試験イメージング市場：モダリティ変動分析
• 臨床試験イメージング市場のモダリティ別展望
• 2018年から2030年までの市場規模と予測および動向分析
• コンピュータ断層撮影スキャン
• 磁気共鳴画像
• X線
• 超音波
• 光干渉断層撮影（OCT）
• その他のモダリティ

第5章 臨床試験イメージング市場：治療領域別推定・動向分析

• セグメントダッシュボード
• 臨床試験イメージング市場：治療領域変動分析
• 臨床試験イメージング市場の治療領域展望
• 2018年から2030年までの市場規模と予測および動向分析
• 神経血管疾患
• 心血管疾患
• 整形外科とMSK障害
• 腫瘍学
• 眼科
• 腎臓学
• その他の治療領域

第6章 臨床試験イメージング市場：サービス別推定・動向分析

• セグメントダッシュボード
• 臨床試験イメージング市場：サービス変動分析
• 臨床試験イメージング市場のサービス展望
• 2018年から2030年までの市場規模と予測および動向分析
• 臨床試験の設計とコンサルティングサービス
• リーディングおよび分析サービス
• 運用イメージングサービス
• システムおよびテクノロジーサポートサービス
• プロジェクトとデータ管理

第7章 臨床試験イメージング市場：最終用途別推定・動向分析

• セグメントダッシュボード
• 臨床試験イメージング市場：最終用途変動分析
• 臨床試験イメージング市場の最終用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• バイオテクノロジーおよび製薬企業
• 医療機器メーカー
• 学術機関および政府研究機関
• 受託研究機関（CRO）
• その他のエンドユーザー

第8章 臨床試験イメージング市場：地域別推定・動向分析

• 地域別市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 世界地域市場のスナップショット
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2024年
  • IXICO plc
  • Navitas Life Sciences
  • Resonance Health
  • ProScan Imaging
  • Radiant Sage LLC
  • Medpace
  • Biomedical Systems Corp.
  • Cardiovascular Imaging Technologies
  • Intrinsic Imaging
  • BioTelemetry

List of Tables

• Table 1 List of Abbreviation
• Table 2 North America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 3 North America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 4 North America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 5 North America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 6 North America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 8 U.S. clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 9 U.S. clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 10 U.S. clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 11 Canada clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 12 Canada clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 13 Canada clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 14 Canada clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 15 Mexico clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 16 Mexico clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 17 Mexico clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 18 Mexico clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 20 Europe clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 21 Europe clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 22 Europe clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 23 Europe clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 24 Germany clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 25 Germany clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 26 Germany clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 27 Germany clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 28 UK clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 29 UK clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 30 UK clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 31 UK clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 32 France clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 33 France clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 34 France clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 35 France clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 36 Italy clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 37 Italy clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 38 Italy clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 39 Italy clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 40 Spain clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 41 Spain clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 42 Spain clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 43 Spain clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 44 Sweden clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 45 Sweden clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 46 Sweden clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 47 Sweden clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 48 Denmark clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 49 Denmark clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 50 Denmark clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 51 Denmark clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 52 Norway clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 53 Norway clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 54 Norway clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 55 Norway clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 61 China clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 62 China clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 63 China clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 64 China clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 65 Japan clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 66 Japan clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 67 Japan clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 68 Japan clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 69 India clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 70 India clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 71 India clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 72 India clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 73 Australia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 74 Australia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 75 Australia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 76 Australia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 77 South Korea clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 78 South Korea clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 79 South Korea clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 80 South Korea clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 81 Thailand clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 82 Thailand clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 83 Thailand clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 84 Thailand clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 85 Latin America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 86 Latin America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 87 Latin America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 88 Latin America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 89 Latin America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 90 Brazil clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 91 Brazil clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 92 Brazil clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 93 Brazil clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 94 Argentina clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 95 Argentina clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 96 Argentina clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 97 Argentina clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 98 Middle East and Africa clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 99 Middle East and Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 100 Middle East and Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 101 Middle East and Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 102 Middle East and Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 103 South Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 104 South Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 105 South Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 106 South Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 111 UAE clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 112 UAE clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 113 UAE clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 114 UAE clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 115 Kuwait clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 116 Kuwait clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 117 Kuwait clinical trial imaging market, by services, 2018 - 2030 (USD Million)
• Table 118 Kuwait clinical trial imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 clinical trial imaging market: market outlook
• Fig. 14 clinical trial imaging market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Clinical trial imaging market driver impact
• Fig. 20 Clinical trial imaging market restraint impact
• Fig. 21 Clinical trial imaging market strategic initiatives analysis
• Fig. 22 Clinical trial imaging market: Modality movement analysis
• Fig. 23 Clinical trial imaging market: Modality outlook and key takeaways
• Fig. 24 Computed tomography scan market estimates and forecast, 2018 - 2030
• Fig. 25 Magnetic resonance imaging market estimates and forecast, 2018 - 2030
• Fig. 26 X-Ray market estimates and forecast, 2018 - 2030
• Fig. 27 Ultrasound market estimates and forecast, 2018 - 2030
• Fig. 28 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
• Fig. 29 Other modalities market estimates and forecast, 2018 - 2030
• Fig. 30 Clinical trial imaging market: Therapeutic area movement analysis
• Fig. 31 Clinical trial imaging market: Therapeutic area outlook and key takeaways
• Fig. 32 Neurovascular diseases market estimates and forecast, 2018 - 2030
• Fig. 33 Cardiovascular diseases market estimates and forecast, 2018 - 2030
• Fig. 34 Oncology market estimates and forecast, 2018 - 2030
• Fig. 35 Ophthalmology market estimates and forecast, 2018 - 2030
• Fig. 36 Nephrology market estimates and forecast, 2018 - 2030
• Fig. 37 Other therapeutic areas market estimates and forecast, 2018 - 2030
• Fig. 38 Clinical trial imaging market: Services movement analysis
• Fig. 39 Clinical trial imaging market: Services outlook and key takeaways
• Fig. 40 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
• Fig. 41 Reading and analytical services market estimates and forecast, 2018 - 2030
• Fig. 42 Operational imaging services market estimates and forecast, 2018 - 2030
• Fig. 43 System and technology support services market estimates and forecast, 2018 - 2030
• Fig. 44 Project and data management market estimates and forecast, 2018 - 2030
• Fig. 45 Clinical trial imaging market: End use movement analysis
• Fig. 46 Clinical trial imaging market: End use outlook and key takeaways
• Fig. 47 Biotechnology companies market estimates and forecast, 2018 - 2030
• Fig. 48 Medical devices manufacturers market estimates and forecast, 2018 - 2030
• Fig. 49 Academic and government research institutes market estimates and forecast, 2018 - 2030
• Fig. 50 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
• Fig. 51 Other end users market estimates and forecast, 2018 - 2030
• Fig. 52 Global clinical trial imaging market: Regional movement analysis
• Fig. 53 Global clinical trial imaging market: Regional outlook and key takeaways
• Fig. 54 Global market shares and leading players
• Fig. 55 North America market share and leading players
• Fig. 56 Europe market share and leading players
• Fig. 57 Asia Pacific market share and leading players
• Fig. 58 Latin America market share and leading players
• Fig. 59 Middle East & Africa market share and leading players
• Fig. 60 North America
• Fig. 61 North America market estimates and forecast, 2018 - 2030
• Fig. 62 U.S.
• Fig. 63 U.S. market estimates and forecast, 2018 - 2030
• Fig. 64 Canada
• Fig. 65 Canada market estimates and forecast, 2018 - 2030
• Fig. 66 Mexico
• Fig. 67 Mexico market estimates and forecast, 2018 - 2030
• Fig. 68 Europe
• Fig. 69 Europe. market estimates and forecast, 2018 - 2030
• Fig. 70 UK
• Fig. 71 UK market estimates and forecast, 2018 - 2030
• Fig. 72 Germany
• Fig. 73 Germany market estimates and forecast, 2018 - 2030
• Fig. 74 France
• Fig. 75 France market estimates and forecast, 2018 - 2030
• Fig. 76 Italy
• Fig. 77 Italy market estimates and forecast, 2018 - 2030
• Fig. 78 Spain
• Fig. 79 Spain market estimates and forecast, 2018 - 2030
• Fig. 80 Sweden
• Fig. 81 Sweden market estimates and forecast, 2018 - 2030
• Fig. 82 Denmark
• Fig. 83 Denmark market estimates and forecast, 2018 - 2030
• Fig. 84 Norway
• Fig. 85 Norway market estimates and forecast, 2018 - 2030
• Fig. 86 Asia Pacific
• Fig. 87 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 88 China
• Fig. 89 China market estimates and forecast, 2018 - 2030
• Fig. 90 Japan
• Fig. 91 Japan market estimates and forecast, 2018 - 2030
• Fig. 92 India
• Fig. 93 India market estimates and forecast, 2018 - 2030
• Fig. 94 Australia
• Fig. 95 Australia market estimates and forecast, 2018 - 2030
• Fig. 96 South Korea
• Fig. 97 South Korea market estimates and forecast, 2018 - 2030
• Fig. 98 Thailand
• Fig. 99 Thailand market estimates and forecast, 2018 - 2030
• Fig. 100 Latin America
• Fig. 101 Latin America market estimates and forecast, 2018 - 2030
• Fig. 102 Brazil
• Fig. 103 Brazil market estimates and forecast, 2018 - 2030
• Fig. 104 Argentina
• Fig. 105 Argentina market estimates and forecast, 2018 - 2030
• Fig. 106 Middle East and Africa
• Fig. 107 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 108 Saudi Arabia
• Fig. 109 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 110 South Africa
• Fig. 111 South Africa market estimates and forecast, 2018 - 2030
• Fig. 112 UAE
• Fig. 113 UAE market estimates and forecast, 2018 - 2030
• Fig. 114 Kuwait
• Fig. 115 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 116 Participant categorization- Clinical trial imaging market
• Fig. 117 Market share of key market players- Clinical trial imaging market

Clinical Trial Imaging Market Growth & Trends:

The global clinical trial imaging market size is expected to reach USD 1.91 billion by 2030, registering a CAGR of 7.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

Clinical Trial Imaging Market Report Highlights:

• The reading and analytical services segment held the largest market share at 30.95% in 2024 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, highlighting its critical role in ensuring the accuracy and reliability of imaging data in clinical research.
• The biotechnology and pharmaceutical companies segment accounted for the largest share of 28.7% in 2024. The factor attributing to the dominance of this segment is the need to develop new drugs and therapies to cure chronic diseases.
• Oncology segment held the largest market share of 23.63% in 2024. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.
• The contract research organizations (CROs) segment is expected to grow significantly with a CAGR of 8.5% over the forecast period, owing to its essential role in developing new drugs and therapies for chronic diseases.
• North America dominated the market with a revenue share of 47.93% in 2024 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Therapeutic Area
  • 1.2.3. Services
  • 1.2.4. End Use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Therapeutic area outlook
  • 2.2.3. Services outlook
  • 2.2.4. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing number of pharmaceutical and biotechnological companies
    • 3.2.1.2. Growing number of contract research organization (CRO)
    • 3.2.1.3. Increasing research and development investments
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of machineries and installations
• 3.3. Clinical Trial Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Clinical Trial Imaging Market: Modality Movement Analysis
• 4.3. Clinical Trial Imaging Market by Modality Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Computed Tomography Scan
  • 4.5.1. Computed Tomography Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Magnetic Resonance Imaging
  • 4.6.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. X-Ray
  • 4.7.1. X-Ray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Ultrasound
  • 4.8.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Optical Coherence Tomography (OCT)
  • 4.9.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.10. Other Modalities
  • 4.10.1. Other Modalities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Imaging Market: Therapeutic Area Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Clinical Trial Imaging Market: Therapeutic Area Movement Analysis
• 5.3. Clinical Trial Imaging Market by Therapeutic Area Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Neurovascular Diseases
  • 5.5.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Cardiovascular Diseases
  • 5.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Orthopedics & MSK Disorders
  • 5.7.1. Orthopedics & MSK Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Oncology
  • 5.8.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Ophthalmology
  • 5.9.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. Nephrology
  • 5.10.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.11. Other Therapeutic Areas
  • 5.11.1. Other Therapeutic Areas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Imaging Market: Services Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Clinical Trial Imaging Market: Services Movement Analysis
• 6.3. Clinical Trial Imaging Market by Services Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Clinical Trial Design and Consultation Services
  • 6.5.1. Clinical Trial Design and Consultation Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Reading and Analytical Services
  • 6.6.1. Reading and Analytical Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Operational Imaging Services
  • 6.7.1. Operational Imaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. System and Technology Support Services
  • 6.8.1. System and Technology Support Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Project and Data Management
  • 6.9.1. Project and Data Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Clinical Trial Imaging Market: End Use Movement Analysis
• 7.3. Clinical Trial Imaging Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Biotechnology and Pharmaceutical Companies
  • 7.5.1. Biotechnology and Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Medical Devices Manufacturers
  • 7.6.1. Medical Devices Manufacturers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Academic and Government Research Institutes
  • 7.7.1. Academic and Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Contract Research Organizations (CROs)
  • 7.8.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Other End Users
  • 7.9.1. Other End Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.8.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.8.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.8. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. Middle East & Africa
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.1.1 Company/Competition Categorization
  • 9.1.2. Innovators
• 9.2. Vendor Landscape
  • 9.2.1. List of key distributors and channel partners
  • 9.2.2. Key customers
  • 9.2.3. Key company market share analysis, 2024
  • 9.2.4. IXICO plc
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Navitas Life Sciences
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Resonance Health
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. ProScan Imaging
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Radiant Sage LLC
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Medpace
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Biomedical Systems Corp.
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. Cardiovascular Imaging Technologies
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives
  • 9.2.12. Intrinsic Imaging
    • 9.2.12.1. Company overview
    • 9.2.12.2. Financial performance
    • 9.2.12.3. Product benchmarking
    • 9.2.12.4. Strategic initiatives
  • 9.2.13. BioTelemetry
    • 9.2.13.1. Company overview
    • 9.2.13.2. Financial performance
    • 9.2.13.3. Product benchmarking
    • 9.2.13.4. Strategic initiatives